-
More Treatment Options Proposed For People With Multiple Myeloma And Myelodysplastic Syndrome
23 Apr 2024 01:55 GMT
… more treatments for people with a type of blood cancer,
… and Assessment/Chief Medical Officer, Dr
David Hughes. … having access to these medicines is desperately needed. We … brand change.
Revlimid would be delisted from the Pharmaceutical Schedule
on …
-
Joe Biden - Fact-checking Biden’s statement on prescription costs for Medicare including cancer drugs
18 Apr 2024 21:02 GMT
… some expensive cancer drugs delivered in doctors’ offices — as with chemotherapy — are not … enrollees — Revlimid, Pomalyst, Imbruvica, Jakafi and Ibrance, all cancer treatments — annual … says
RELATED: Biden said Medicare drug price negotiations cut the …
-
FDA advisers back new endpoint for myeloma approvals, paving way for faster introduction of new drugs
12 Apr 2024 23:40 GMT
… In the MRD approach, doctors or trial investigators search patients’ bone … treatments for early breast cancer. The level of MRD’s trial- … what clinical trials are all about.”
As the FDA looks on … , Bristol Myers Squibb’s Revlimid and dexamethasone (KRd) was …
-
New, Emerging Treatment Options for Patients With Multiple Myeloma
12 Apr 2024 21:07 GMT
… of medicine, Mayo Clinic Comprehensive Cancer Center, highlighted new treatment options … Janssen Biotech, Inc)—which was approved by the FDA about … with results presented in trials evaluating CAR T therapies … initial single-arm trial looked at iberdomide with …
-
As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake
09 Apr 2024 20:56 GMT
… ,” Landgren said, “and pharmaceutical companies, it’s in … is testing its Legend Biotech-partnered CAR-T therapy … Sarclisa, Amgen’s Kyprolis, Revlimid and dexamethasone (KRd) was … to cancer drugs for earlier treatment lines with the same randomized trial …
-
FDA Approves Carvykti for Relapsed, Refractory Myeloma
08 Apr 2024 18:06 GMT
… Revlimid (lenalidomide) and previously received a proteasome inhibitor and an immunomodulatory drug … the FDA’s Oncologic Drugs Advisory … CARTITUDE-4 trial, which showed … treatment sequence,” Dr. Irene Ghobrial, professor of medicine at the Dana-Farber Cancer …
-
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies
06 Apr 2024 17:48 GMT
… antipsychotics. The drugmaker gained access to the treatment, called KarXT … the course of the trial, with 17.6% of … trials, 14.9% of patients discontinued the study due to treatment … Myers' top drugs, blood cancer treatment Revlimid and blood thinner Eliquis …
-
FDA Approves Abecma for Pretreated R/R Multiple Myeloma
05 Apr 2024 18:57 GMT
…
In the KarMMa-3 trial, at an approximate median … responded partially or completely to treatment) of 71%, with … dexamethasone (DVd); Ninlaro (ixazomib), Revlimid (lenalidomide) and dexamethasone (IRd); …
For more news on cancer updates, research and education, …
-
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
05 Apr 2024 18:20 GMT
… acquired cancer-focused biotech Seagen, and the intriguing drug pipeline … drugs that are going off-patent. Specifically, Revlimid … drug. Indeed, the COVID-19 windfall helped it finance other mRNA treatments … potential behind its cancer vaccines. That said, …
-
FDA approves CAR-T therapies from J&J, Bristol Myers for earlier myeloma use
05 Apr 2024 17:56 GMT
… use treating the blood cancer, granting expanded approvals to … with Legend Biotech.
Dive Insight:
Overall, trial results showed … a panelist and associate medical professor at the University … be resistant to treatment with a drug called Revlimid.
"This …